Following is a comment from Beth Levine, spokesperson for Ranking Member Grassley, in response to the letter sent to Senators Grassley and Leahy and Congressmen Issa, Smith, Cummings and Conyers from Attorney General Holder.

"The goals of Senator Grassley's investigation, from the first time whistleblowers brought him the allegations of wrongdoing, has been to find out who approved a stupid program and to make sure it never happened again.  He believed he owed those answers to the family of slain Border Patrol Agent Brian Terry, especially since the family wasn't getting answers from the executive branch.  Instead of helping get to the bottom of the disastrous program, the Justice Department stonewalled Senator Grassley's investigation and denied him access to documents and key personnel.  If the Attorney General had come clean with Congress from the beginning instead of having his staff send false and misleading responses to Senator Grassley's letters (Jan. 27th letter and January 31st letter) , then the public discussion of these issues could have been more productive.

"Now, eight months after Senator Grassley personally raised the issue with him, Attorney General Holder has officially admitted that this case involved 'weapons that should have been interdicted but were not.'  That's quite a reversal from the Department's initial denial, which claimed the whistleblower allegations were false and that 'ATF makes every effort to interdict weapons that have been purchased illegally.'

"Documents provided last week make clear that (1) senior officials discussed whether it would be wise for the head of the Department's Criminal Division to attend press events given the number of guns that were walked, (2) the Attorney General's current chief of staff took notes regarding operational details during a presentation on Operation Fast and Furious in March 2010, and (3) the connection between the guns found at Agent Terry's murder scene and Operation Fast and Furious was immediately briefed up to the Attorney General's current chief of staff just two days after Agent Terry's death.

"These documents raise as many questions as they answer about which senior Department officials knew what about Operation Fast and Furious.  In addition to these documents, getting at the truth also requires taking testimony from the key officials involved.  The Attorney General's denials of any personal knowledge will have to be tested against all the evidence as the investigation continues, just as the Department's initial denials were."

Q:        How is The World Food Prize tied to Iowa?

A:        Two Iowans were behind creation of the World Food Prize, the international award recognizing individuals who improve the quality, quantity and availability of food in the world.  Dr. Norman Borlaug (1914-2009) -- an agronomist, humanitarian, Nobel laureate (the only recipient to receive this honor for working in agriculture), and recipient of the Presidential Medal of Freedom and the Congressional Gold Medal -- grew up in rural Cresco.  He was the father of what's called the Green Revolution when, from the 1940s to the 1970s, research, development and new technologies increased agricultural production around the world.  Dr. Borlaug was involved with the development of high-yielding varieties of cereal grains, expansion of irrigation infrastructure, modernization of management techniques, and the distribution of hybridized seeds, synthetic fertilizers and pesticides to farmers.  Dramatically increasing crop yields saved hundreds of millions of people from starvation.  Dr. Borlaug's leadership and tireless work gave the world's poorest people access to food.  It's said that he saved more lives than any other person in history.  Dr. Borlaug envisioned a prize as a means of recognizing and inspiring achievements in fighting world hunger.  His vision was realized in 1986, when The World Food Prize was created.  In 1990, the first sponsor of the prize withdrew, and Iowa businessman and leading philanthropist John Ruan (1914-2010) stepped forward to endow the prize, making it possible to continue Dr. Borlaug's vision.  The World Food Prize organization is located in Des Moines.

 

Q:        Who is considered for the prize?

A:        Contributions by individuals in any field that's involved in the world food supply - including food and agricultural science and technology, manufacturing, marketing, nutrition, economics, poverty alleviation, political leadership, and the social sciences - are recognized by The World Food Prize.  The prize values a nutritious and sustainable food supply for all people.  Outstanding individuals from Bangladesh, Brazil, China, Cuba, Denmark, Ethiopia, India, Mexico, Sierra Leone, Switzerland, the United Kingdom, the United Nations, and the United States have received the prize.  It's most fitting that this prestigious award is given each fall in Iowa.  Iowa farmers are blessed with some of the best soil in the world, and our state's productivity and agricultural abundance have made significant contributions to global food security, humanitarian relief, economic growth, job creation and national security.

 

Friday, October 7, 2011

Grassley Questions Agency on Decision to Shut Down Public File on Disciplined Doctors

WASHINGTON - Sen. Chuck Grassley of Iowa today asked the head of a federal agency to explain a decision to shut down public access to data on malpractice payouts, hospital discipline and regulatory sanctions against doctors and other health professionals.  The public data file did not include doctors' names, only data that would allow journalists and analysts to track trends in disciplinary actions.  The Health Research and Services Administration shut down the public file after a newspaper reporter used the publicly available information to track down the identity of a doctor who had a long record of malpractice cases against him but was never disciplined by the state.

"Shutting down public access to the data bank undermines the critical mission of identifying inefficiencies within our health care system - particularly at the expense of Medicare and Medicaid beneficiaries," Grassley wrote in his letter to the agency.  "More transparency serves the public interest. Generally speaking, except in cases of national security, the public's business ought to be public.  Providers receive billions of dollars in state and federal tax dollars to serve Medicare and Medicaid beneficiaries. Accountability requires tracking how the money is spent."

The text of Grassley's letter is available here.   More information on how journalists have used the public database to inform the public is available here.

-30-
WASHINGTON - October 7, 2011 - Senator Chuck Grassley and Congressman Darrell Issa today said that Attorney General Eric Holder received at least five weekly memos beginning in July 2010, including four weeks in a row, describing the ill-advised strategy known as Operation Fast and Furious.  The memos were to Holder from Michael Walther, the director of the National Drug Intelligence Center.

The Attorney General told Issa during a House Judiciary Committee in May 2011 that he had just learned of Fast and Furious a few weeks before.  Yet, on January 31, in a previously scheduled meeting, Grassley personally handed him two letters about Fast and Furious. Grassley and Issa said they find it very troubling that Holder actually knew of Operation Fast and Furious much earlier, and in greater detail than he ever let on.

The memos specifically said that the straw buyers were "responsible for the purchase of 1500 firearms that were then supplied to Mexican drug trafficking cartels."

"With the fairly detailed information that the Attorney General read, it seems the logical question for the Attorney General after reading in the memo would be "why haven't we stopped them?" Grassley said.  "And if he didn't ask the questions, why didn't he or somebody in his office?"

"Attorney General Holder has failed to give Congress and the American people an honest account of what he and other senior Justice Department officials knew about gunwalking and Operation Fast and Furious. The lack of candor and honesty from our nation's chief law enforcement officials in this matter is deeply disturbing," Issa said.

Grassley and Issa have been leading the investigation into who approved the strategy to allow guns to be purchased by known straw buyers who then often transferred the firearms to Mexican Drug Cartels.

The memos can be found here.


Prepared Statement of Ranking Member Chuck Grassley

Senate Committee on the Judiciary

Executive Business Meeting

Thursday, October 6, 2011

 

Mr. Chairman,

With regard to the judicial nominations, we are prepared to vote on the following nominations today:  Wallach, Christensen, Bencivengo, Groh, and Brodie.   We have a request on our side for a roll call vote on Wallach.  There are requests on our side to hold over the following nominees, who are appearing for the first time on our agenda:  Jordán, Gerrard, Phillips, Rice, Nuffer, Frank, Pane, and Webb.

 

We have a number of bills on the agenda today that appear for the first time.  We have a request on our side to hold over all of them for consideration next week.

On the legislation, I would like to say a few words about S.1301, the Trafficking Victims Protection Reauthorization Act.  We held a hearing on this legislation just three weeks ago that focused on the administration of programs designed to help victims of trafficking.

It is my hope that that the administration will get back to us with the questions we submitted for the record so we can consider those as part of our discussion on the bill next week.

I am pleased to report that my staff and the Chairman's have been working together for the last few weeks to find common ground on this issue.  However, there are changes needed in the draft to ensure that we recognize the changing times and the current fiscal crisis.  We need to ensure that our resources are carefully spent and are only provided to programs that are working.

At the hearing, I raised my concerns with the Department of Justice about a number of audits that have been conducted showing shocking examples of waste and abuse of grants.  I highlighted how the Inspector General had pulled nine specific grants and reviewed them for compliance.  All nine of those audits found hundreds of thousands of dollars in questioned costs, unauthorized expenditures, failed matching requirements, questioned salaries and fringe benefits, and many other problems.

I raised these audits with the witness from the Department of Justice, Office of Justice Programs who admitted that one audit that questioned over $1.3 million of a $1.7 million grant, showed that the grant was a failure.  This is unacceptable and the American taxpayers deserve better.  These audits demand our attention and that is why we "reauthorize" these programs?to make sure the money isn't being wasted.

Yet, here, we have audits showing that money is being wasted.  So we have the opportunity and responsibility to fix this.  Our efforts to reauthorize this legislation need to fix this problem and ensure that grantees that commit violations like this never see another federal dollar.  We need transparency, accountability, and performance from grantees that are trusted with federal dollars.  Absent any of these three things, they should not receive any money.

Further, we need to hold accountable the Justice Department, State Department, and other federal agencies that award trafficking grants under the TVPA.  These bureaucracies often turn a blind eye to the waste, abuse, and mismanagement of these grants, leading up to these audits.

Too often, the agencies simply fail to conduct the oversight required of the grants and then plead ignorant when the Inspector General finds problems.  This too has to stop.  Both the grant managers and the grantees should be held accountable.  It starts at the top with the head of the agency and we need those in power at these agencies to question spending, not just push taxpayer dollars out the door.

Unfortunately, as the recent report on conference expenditures at the Justice Department points out, it's clear this Justice Department doesn't understand that.  We all heard about the infamous $16 muffins and all the hay the hotels and the Justice Department have raised to refute the finding.  Well, what they can't hide from is the fact that since President Obama took office, conference spending at the Justice Department has nearly doubled from the Bush administration.

In fiscal 2008, the Justice Department spent $47.8 million on conferences.  In President Obama's first year, Fiscal Year 2009, that increased to $73.3 million.  Last year, it increased further to $91.5 million.  That is not fiscal responsibility, that's excess and waste.

The point is, we are well past the time when we can reauthorize programs without giving them the scrutiny needed.  We have a Justice Department that is addicted to spending without control and we need to rein that in.  We need to use this opportunity to ensure that hard earned taxpayer dollars are going to the people we are trying to help, here that's the victims of trafficking.  If we continue to allow grants to be mismanaged, a victim who could have been helped goes without.

I hope the Chairman and I can continue our work and reach an agreement on this bill for next week.  Thank you.

-30-


Opening Statement of Ranking Member Chuck Grassley

Senate Committee on the Judiciary

The Role of Judges in our Constitutional System

Wednesday, October 5, 2011

Thank you, Mr. Chairman, for holding today's hearing.  I appreciate your efforts to secure the testimony of our distinguished witnesses.  I hope that this hearing will be an enlightening experience in which we will discuss the role of judges in our constitutional system.  This is a question as old as the Constitution itself and it will always be debated.

I extend a welcome to each of our witnesses.  Justice Breyer, let me extend a welcome back to the Senate Judiciary Committee to you.  As the chairman stated, you are a former chief counsel of this Committee.  I remind you of your statement in your recent book, "Criticism of judges and judicial decisions traces back to our founding.  It is a healthy thing in a democracy."  I hope you will feel that way as much at the end of the hearing as you did then.  We know that you did not have to appear before us, and that your schedule is very busy, so we appreciate that you both have agreed to speak to us.

Justice Scalia, I'm also glad to see you here today.  As Judge Posner recently remarked, you have "a real flair for judging."  I think that is an understatement.  You as much as anyone have strongly advanced the traditional view that a judge's role under the Constitution is to interpret the law according to its text and history.

For my own part, I believe that the role of judges under the Constitution is an important but limited one.  Unless the Constitution provides otherwise, the people through their elected representatives govern themselves.  In determining the meaning of the Constitution, judges are to apply the intent of the Framers, since that is the extent of the limitation on self-government that the people have agreed to impose on themselves.  When judges change the meaning of the Constitution and create new rights, or grant the government powers that it was not intended to have, they reduce the right of the people to govern themselves through the representative government process.  Historically, these are the circumstances in which judges and their decisions have been fairly criticized.

It is rare for sitting Supreme Court Justices to appear before the Senate Judiciary Committee.  I look forward to your testimony as well as the chance to discuss these important questions with you.-30-

Monday, October 3, 2011

More Conference Expenditures Placed Under Microscope

WASHINGTON - Senator Chuck Grassley has inquired about taxpayer dollars being spent on yet another conference, this time in Tokyo, as part of an "International Series" of conferences according to the Federal Circuit Court of Appeals website.  The intellectual property conference is being sponsored, in part, by the U.S. Patent and Trademark Office to the tune of $189,600.  The office is also sending several employees to the conference. In addition, the Federal Circuit Court of Appeals is apparently sending up to eight people to the international conference.

Grassley has previously looked at conference expenditures, most recently following a Justice Department Inspector General's office report outlining unacceptable amounts of spending.

"Between 2008 and 2010, spending on conferences at the Justice Department increased from $47.8 million to $91.5 million.  The Justice Department may or may not be the only bad egg in the bunch, but they helped shine a light on outrageous spending, just when we need to be tightening our belt.  A nearly $200,000 conference appears to be just why we need to put a microscope on conference expenses at agencies across the federal government," Grassley said.

Grassley sent letters to both the Department of Commerce and the Administrative Office of the U.S. Courts asking questions about the Tokyo conference and the "International Series."

Here are copies of the text of the letters.  Copies of the signed letters to the Department of Commerce and the Administrative Office of the U.S. Courts can be found here.

 

VIA ELECTRONIC TRANSMISSION

The Honorable Rebecca M. Blank

Acting Secretary

U.S. Department of Commerce
1401 Constitution Ave., NW
Washington, DC 20230

Dear Acting Secretary Blank:

I am writing because of information that I have received about spending related to an intellectual property conference in Tokyo, Japan, which is scheduled for late October 2011.  I am concerned about the amount of taxpayer dollars spent by Administrative agencies for conferences, seminars and travel, especially during this time of fiscal constraint.

 

The website for the Federal Circuit Court of Appeals (CAFC) states that the conference is part of an "International Series" of conferences that was developed in November 2010 to "look for the 'best practices in legal systems' worldwide and 'how those practices?both in terms of governance and the practice of law?relate to innovation and the betterment of societies.'" The website lists the Department of Commerce and the United States Patent & Trademark Office (USPTO) among those funding the conferences.  It is my understanding that the USPTO is spending approximately $189,600 to sponsor the Tokyo conference.

 

According to information I have received from a whistleblower, the USPTO will be sending at least four participants to the Tokyo conference, including its Director, Deputy Director and its Deputy General Counsel and the CAFC will be sending as many as eight participants including: the Chief Judge of the court, five other Circuit Judges, the Circuit Executive and Clerk of the court.

Consequently, I have a number of questions about the Tokyo conference, other conferences sponsored by USPTO and/or its affiliate, the Global Intellectual Property Academy (GIPA), and the amount of government funds being spent on travel by the USPTO.  Accordingly, please respond to the following requests for information:

 

  1. Has the USPTO previously sponsored or is it committed to sponsor any of the conferences in the International Series?  If so, for each such conference, set forth the date(s), location, title and subject matter.  Also, for each such conference, set forth how much the USPTO paid or is planning to pay to be a sponsor.

 

  1. Has the USPTO paid for any of its employees to attend any of the past conferences in the International Series?  If so, for each such conference, identify by name and title, the employee(s) who attended.  Also, for each such conference identify the date(s), location, title and subject matter.  Finally, for each such conference, set forth how much the USPTO paid for the employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. Is the USPTO planning to pay for any of its employees to attend the Tokyo conference?  If so, identify by name and title, the employee(s) who are scheduled to attend.  Also, set forth how much the USPTO is planning to spend in connection with its employees attending, broken down by: (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. If you submit your responses after the Tokyo conference has taken place and employees attended, identify by name and title, the employee(s) who actually attended, if any.  Also, if applicable, set forth how much the USPTO actually paid for the employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. Other than the Tokyo conference, is the USPTO planning on paying to have any of its employees attend any of the other conferences in the International Series?  If so, for each such conference, identify by name and title, the employee(s) who are scheduled to attend.  If specific individuals are not yet scheduled to attend, for each conference set forth how many individuals the USPTO is planning on paying for.  Also, for each such conference identify the date(s), location, title and subject matter.  Finally, for each such conference, set forth how much the USPTO is planning to pay for its employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. During the last three years, has the USPTO sponsored any conferences or seminars?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  Also, for each such conference or seminar, set forth how much the USPTO paid to be a sponsor.

 

  1. During the last three years, has the USPTO paid for any of its employees to attend a conference or seminar?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  And for each such conference/seminar, identify by name and title, the employee(s) who attended.  Also, for each conference or seminar, set forth how much the USPTO paid for the employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. During the next three years, is the USPTO planning to sponsor any conferences or seminars?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  Also, for each such conference or seminar, set forth how much the USPTO is planning to pay to be a sponsor.

 

  1. During the next three years, is the USPTO planning to pay for any of its employees to attend a conference or seminar?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  Also, for each such conference or seminar, set forth how much the USPTO is planning to pay for its employee(s) to attend.  If possible break down those amounts by: (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. Does the USPTO have a policy governing its sponsorship of conferences or seminars?  If so, and if that policy is in writing, provide a copy of the document.  If the USPTO has a policy but it is not in writing, set forth the policy and explain why it is not a written policy.

 

  1. Does the USPTO have a policy governing its paying for its employees to attend conferences or seminars?  If so, and if that policy is in writing, provide a copy of the document.  If the USPTO has a policy but it is not in writing, set forth the policy and explain why it is not a written policy.

 

These are basic questions, the answers to which should be readily available. Please respond in writing by October 14, 2011.

Should you have any questions, please do not hesitate to contact Janet Drew or Tristan Leavitt of my staff at (202) 224-5225.

Thank you for your attention to this matter.

Sincerely,

Charles E. Grassley
Ranking Member

 

 

VIA ELECTRONIC TRANSMISSION

Jill Sayenga

Acting Director

Administrative Office of the United States Courts
One Columbus Circle, NE
Washington, D.C. 20544

Dear Acting Director Sayenga:

I am writing because of information that I have received about spending related to an intellectual property conference in Tokyo, Japan, which is scheduled for late October 2011.  I am concerned about the amount of taxpayer dollars the Federal Judiciary and the Administrative Office of the U.S. Courts spend on travel, especially during this time of fiscal constraint.

The website for the Federal Circuit Court of Appeals (CAFC) states that the conference is part of an "International Series" of conferences that was developed in November 2010 to "look for the 'best practices in legal systems' worldwide and 'how those practices?both in terms of governance and the practice of law?relate to innovation and the betterment of societies.'" The website lists the Department of Commerce and the United States Patent & Trademark Office (USPTO) among those funding the conferences.  It is my understanding that the USPTO is spending $189,600 to sponsor the Tokyo conference.

According to information I have received from a whistleblower, the USPTO will be sending at least four participants to the Tokyo conference, including its Director, Deputy Director and its Deputy General Counsel and the CAFC will be sending as many as eight participants including: the Chief Judge of the court, five other Circuit Judges, the Circuit Executive and Clerk of the court.

Consequently, I have a number of questions about the Tokyo conference, the other conferences in the International Series and the amount of government funds being spent on travel by the Federal Judiciary.  Accordingly, please respond to the following requests for information:

 

1. Has the CAFC previously sponsored or is it committed to sponsor any of the conferences in the International Series?  If so, for each such conference, set forth the date(s), location, title and subject matter.  Also, for each such conference, set forth how much the CAFC paid or is planning to pay to be a sponsor.

 

2. Has the CAFC paid for any of its judges or employees to attend any of the past conferences in the International Series?  If so, for each such conference, identify by name and title, the judge(s) and/or employee(s) who attended.  Also, for each such conference identify the date(s), location, title and subject matter.  Finally, for each such conference, set forth how much the CAFC paid for the judge(s) and/or employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

3. Is the CAFC planning to pay for any of its judges or employees to attend the Tokyo conference?  If so, identify by name and title, the judge(s) and/or employee(s) who are scheduled to attend.  Also, set forth how much the CAFC is planning to spend in connection with its judges and/or employees attending, broken down by: (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. If you submit your responses after the Tokyo conference has taken place and CAFC judges or employees attended, identify by name and title, the judge(s) and/or employee(s) who actually attended, if any.  Also, if applicable, set forth how much the CAFC actually paid for the judge(s) and/or employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. Other than the Tokyo conference, is the CAFC planning on paying to have any of its judges or employees attend any of the other conferences in the International Series?  If so, for each such conference, identify by name and title, the judge(s) and/or employee(s) who are scheduled to attend.  If specific individuals are not yet scheduled to attend, for each conference set forth how many individuals the CAFC is planning on paying for.  Also, for each such conference identify the date(s), location, title and subject matter.  Finally, for each such conference, set forth how much the CAFC is planning to pay for its judge(s) and/or employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. During the last three years, has the Federal Judiciary (including the CAFC) sponsored any conferences or seminars?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  Also, for each such conference or seminar, set forth how much the Federal Judiciary paid to be a sponsor.

 

  1. During the last three years, has the Federal Judiciary paid for any of its judge(s) and/or employees to attend a conference or seminar?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  And for each such conference/seminar, identify by name and title, the judge(s) and/or employee(s) who attended.  Also, for each conference or seminar, set forth how much the Federal Judiciary paid for the judge(s) and/or employee(s) to attend, broken down by (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. During the next three years, is the Federal Judiciary planning to sponsor any conferences or seminars?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  Also, for each such conference or seminar, set forth how much the Federal Judiciary is planning to pay to be a sponsor.

 

  1. During the next three years, is the Federal Judiciary planning to pay for any of its judge(s) and/or employees to attend a conference or seminar?  If so, for each such conference or seminar, set forth the date(s), location, title and subject matter.  Also, for each such conference or seminar, set forth how much the Federal Judiciary is planning to pay for its judge(s) or employee(s) to attend.  If possible break down those amounts by: (a) conference fees, (b) travel expenses, (c) hotel expenses, (d) meals and (e) other expenses.

 

  1. Does the Federal Judiciary have a policy governing its sponsorship of conferences or seminars?  If so, and if that policy is in writing, provide a copy of the document.  If the Federal Judiciary has a policy but it is not in writing, set forth the policy and explain why it is not a written policy.

 

  1. Does the Federal Judiciary have a policy governing its paying for its judges or employees to attend conferences or seminars?  If so, and if that policy is in writing, provide a copy of the document.  If the Federal Judiciary has a policy but it is not in writing, set forth the policy and explain why it is not a written policy.

 

These are basic questions, the answers to which should be readily available. Please respond in writing by October 14, 2011.

WASHINGTON - U.S. Senators Chuck Grassley (R-Iowa) and Herb Kohl (D-Wis.) are pressing the Centers for Medicare and Medicaid Services (CMS) on missing a deadline for drafting regulations for the Physician Payment Sunshine Act (Sunshine Act), a new law requiring public disclosure of the financial relationships between physicians and the pharmaceutical, medical device and biologics industries.

"Prompt federal guidance is urgently needed to ensure a smooth path toward increasing disclosure, eliminating conflicts and ultimately providing patients with the tools they need to make informed health choices," Grassley and Kohl wrote in a letter to CMS Administrator Dr. Donald Berwick.

The Sunshine Act requires manufacturers to report all payments to physicians, including consulting fees, honoraria, travel and entertainment, and for the Department of Health and Human Services (HHS) to publicly disclose the identity of the manufacturer, physician, and the drug or device associated with the payment on the internet. Additionally, the law requires manufacturers and group purchasing organizations (GPOs) to report all ownership or investment interests held by physicians or members of their family, and for making that information public. The law required HHS to establish guidance on how manufacturers submit information and how the information would be made available to the public no later than October 1, 2011.

The Sunshine Act was developed by Grassley and Kohl after numerous investigations and hearings revealed that large sums of money were going to physicians for sometimes questionable purposes. Some of these payments were the subject of a federal criminal inquiry which resulted in $400 million in fines and legal costs paid by the major orthopedic medical device manufacturers. Ultimately, Congress passed the Sunshine Act as part of the health care reform law in response to growing concerns over industry payments to physicians and their potential negative effects on patient care and the need to restrain health care costs.

In their letter, Grassley and Kohl also asked why CMS failed to meet the statutory deadline and requested a timeline on establishing regulations.

Manufacturers and GPOs are required to start complying with the law by collecting payment data beginning January 1, 2012, and must begin reporting this information to the government on March 31, 2013. Starting September 30, 2013, the details of these payments must be made available to the public. Violations of the disclosure requirements can result in civil monetary penalties ranging from $1,000 to $100,000.

 

The text of the letter follows.

October 3, 2011

Donald Berwick, M.D., M.P.P

Administrator

Centers for Medicare and Medicaid Services

200 Independence Avenue, S.W.

Washington, D.C. 20201

 

Dear Administrator Berwick:

As authors and sponsors of the Physician Payments Sunshine Act (Sunshine Act), which was included in the Patient Protection and Affordable Care Act, we write today to express our severe disappointment in the Centers for Medicare and Medicaid Services (CMS) for failing to meet the October 1, 2011, deadline to draft the regulations mandated by the health care reform law.

While many interactions between the pharmaceutical and medical device industries and medical professionals are beneficial to medical science and lead to innovation, the Sunshine Act was developed after numerous investigations and hearings revealed that large sums of money were going to physicians for sometimes questionable purposes.  Some of these payments were the subject of a federal criminal inquiry which resulted in $400 million in fines and legal costs paid by the major orthopedic medical device manufacturers.  Ultimately, Congress passed the Sunshine Act in response to growing concerns over industry payments to physicians and their potential negative effects on patient care and efforts to restrain healthcare costs.

Under the provisions of this law, manufacturers are required to report to the Secretary of the Department of Health and Human Services (HHS) all payments to physicians, including consulting fees, honoraria, travel, and entertainment, for public disclosure by the Secretary.  The Secretary is then instructed to include the identity of the manufacturer, the physician, and the drug or device associated with the payment on the internet.  An additional provision requires manufacturers and group purchasing organizations (GPOs) to report all ownership or investment interests held by physicians or members of their family, also for public reporting by the Secretary.  It is our understanding that the Secretary has delegated implementation of this provision to CMS.

Manufacturers and GPOs are required to start complying with the law by collecting data beginning January 1, 2012, and must begin reporting this information to the government on March 31, 2013.  Beginning on September 30, 2013, the details of these payments are to be made available to the public.  Violations of the disclosure requirements can result in civil monetary penalties ranging from $1,000 to $100,000.

In order to ensure that manufacturers had adequate time to comply, the law required that the Secretary establish procedures not later than October 1, 2011, describing how manufactures are to submit information and how the information will be made available to the public.  In addition, in establishing these procedures the Secretary was required to "consult with the Inspector General, affected industry, consumers, consumer advocates and other interested parties to ensure that the information made available to the public is presented in the appropriate context."

The deadline for establishing procedures has passed and there has not been, to our knowledge, adequate consultation with either industry representatives or consumer advocates.  Therefore, we are concerned that CMS's failure to implement the statutory provisions on time with clear guidance, standards and definitions will create confusion among both manufacturers and consumers, potentially placing taxpayer dollars at risk.

Although many of the large pharmaceutical and medical device manufacturers, universities, and even the National Institutes of Health (NIH) have already begun to implement disclosure policies voluntarily, we are concerned that smaller companies are waiting for clarity and direction from CMS and will find the lack of timely guidance burdensome and costly.  Prompt federal guidance is urgently needed to ensure a smooth path toward increasing disclosure, eliminating conflicts, and ultimately providing patients with the tools they need to make informed health choices.

In a conference call with our staff on Friday, September 23, 2011, your agency assured us that you have sent the proposed rule over to the Office of Management and Budget (OMB) for review. So that we may better monitor this progress, please answer the following questions in writing no later than October 14, 2011:

(1)   What is your timetable for implementing the Sunshine Act?

(2)   When did you originally send the proposed rule to the Office of Management and Budget (OMB)?  Please include any dates that follow-up was conducted and for what reason.

(3) Why have you failed to meet the statutory deadline?

(4) What is the anticipated release date of the preliminary regulations?  How long will the regulations be open for comment as required by the statute? What is your timeline for issuing final regulations?

In addition to your written response, please have the appropriate CMS officials contact our staff no later than October 7 to schedule an in-depth briefing on these issues and an open discussion on a path forward that allows both a timely implementation and a robust comment period.

Should you have any questions regarding this letter, please contact Erika Smith of the Senate Judiciary Committee staff at (202) 224-5225 or Jack Mitchell of the Senate Special Committee on Aging staff at (202) 224-5364. Thank you for your immediate attention to this important matter.

Sincerely,

 

Charles E. Grassley                       Herb Kohl

Ranking Member                         Chairman

Committee on the Judiciary                      Senate Special Committee on Aging
Finance Senators Release Report Showing Companies Intentionally Increased Frequency of Home Health Visits to Manipulate Reimbursement Rates

Washington, DC - Senate Finance Committee Chairman Max Baucus (D-Mont.) and senior Finance Committee Member Chuck Grassley (R-Iowa) today released a Finance Committee staff report showing tactics used by major for-profit home health companies to game Medicare.  The result has been waste of taxpayer dollars and the delivery of what could be medically-unnecessary patient care to increase the companies' profits.  Baucus and Grassley initiated the investigation into the improper practices as part of the Committee's oversight role of the Medicare and Medicaid programs and the Senators' ongoing commitment to protect patients and taxpayer dollars from waste, fraud and abuse.

"The gaming of Medicare represents serious abuse of the home health program," said Baucus.  "Elderly patients in the Medicare system should not be used as pawns to increase a company's profits. Especially in these tough economic times, taxpayers simply cannot afford for their dollars to be wasted on unnecessary care.  We are going to continue to crack down on these companies to ensure taxpayer dollars are used efficiently and Medicare patients are protected."

"The reimbursement policy encourages gaming, and gaming is what's occurred.   Companies are doing everything they can to make as much money as possible, whether the patients need the care or not.  The federal government needs to fix the policy that lets Medicare money flow down the drain.  This can't wait until tomorrow.  It should have been done yesterday.  The longer this kind of policy continues, the more Medicare's budget balloons, and the bigger the burden on taxpayers," Grassley said.

In May 2010, Baucus and Grassley began their investigation into home health therapy practices at Amedisys, LHC Group, Gentiva, and Almost Family in response to a media report that these home health companies took advantage of the Medicare therapy payment system by providing medically-unnecessary patient care.

The Committee staff report released today examines documents provided by the companies which show how therapists were encouraged to target the most profitable number of therapy visits, even when patient need may not have required such visits.  In addition, therapy visit records for each company showed concentrated numbers of therapy visits at or just above the point at which a "bonus" payment was triggered by the Medicare program.

Internal documents from three of the four companies, Amedisys, LHC Group and Gentiva, provided evidence of top-down strategies to game Medicare.  Highlights from the report include :

  • Managers encouraged therapists to meet a 10-visit target that would have increased their payments from Medicare.
  • An "A-Team" tasked with developing programs to target the most profitable Medicare therapy treatment patterns.
  • Therapists and regional managers that were pressured to follow new clinical guidelines developed to maximize Medicare reimbursements.
  • Top managers instructed employees to increase the number of therapy visits provided in order to increase case mix and revenue.
  • A competitive ranking system for management aimed at driving therapy visit patterns toward profitable levels.
  • Evidence that management discussed increasing therapy visits and expanding specialty programs to increase revenue.

The Medicare Part A program pays out an estimated $19 billion yearly for home health care.  Fraud, waste and abuse in the health care system cost Americans an estimated $60 billion a year, approximately three percent of total health care spending.

Baucus and Grassley have led numerous major investigations of the health care industry to protect consumers and taxpayer dollars.  Earlier this year, when their investigation found that the drug company Sanofi interfered in the approval of generic alternatives to its blood-thinner drug Lovenox, the Finance leaders called on the Food and Drug Administration (FDA) to help guarantee consumers have access to affordable generic medications.  Last December, Baucus and Grassley released a report detailing the relationship between Abbott labs and a Maryland doctor who allegedly implanted nearly 600 unnecessary cardiac stents into his patients, costing the federal government as much as $3.8 million in overpayments.  The specific stent case highlighted in the Senators' report is indicative of a widespread, national problem of unnecessary stenting.  The Senators also spearheaded a two year inquiry which revealed undisclosed side effects of the diabetes drug Avandia.  This resulted in the FDA restricting use of the drug, ensuring that patients and doctors have the information they need to make safe, informed decisions about their medication.

The Committee's full report is available here.

###

WASHINGTON - Sen. Chuck Grassley of Iowa has asked the top watchdog of stimulus money whether the office received any indications of problems regarding now-defunct energy company Solyndra and whether the watchdog office plans to take any action going forward to try to account for the $528 million in stimulus funds awarded to the company and now lost.

"The stimulus funds always needed aggressive oversight," Grassley said.  "Whenever tax money goes out, especially in the billions of dollars, there's tremendous potential for waste, fraud and abuse without checks and balances. The stimulus oversight office should do everything it can to fill in the knowledge gaps regarding what happened to the $528 million in stimulus funds given to Solyndra."

Grassley wrote to the chairman of the Recovery Accountability and Transparency Board, which oversees the implementation of the $787 billion economic stimulus package signed into law by President Obama in February 2009.  Grassley has worked to ensure the board's independence as he has raised specific projects to the board's attention, including stimulus funds misused by the Philadelphia Housing Authority.

The text of Grassley's letter on Solyndra is available here.

Pages